NJ BIO ACQUISITION
China’s India headache: The growing pharmaceutical industryIndian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring trend and a desir...
Suven Pharma sets sights on M&As to scale up tech expertise & order bookSuven Pharmaceuticals, backed by Advent International, is eyeing further mergers and acquisitions to bolster its capabilities and order boo...
Suven Pharma to acquire 56 pc stake in US-based firm for USD 64.4 mnSuven Pharmaceuticals will acquire a 56% stake in US-based NJ Bio Inc for USD 64.4 million. This acquisition aligns with Suven's goal of be...
- Load More